All contents of this page are
from TCT 2008 Late Breaking Trials and "First Report"
Randomized Trials and Registries, October 14 (Tuesday)~16 (Thursday),
Washington Convention Center.
| |
Summarized by
Won-Jang Kim, MD (Asan Medical Center) |
| 1. |
ISAR-LM:
Randomized Comparison of Sirolimus-& Paclitaxel- Eluting
Stents
Source: Presented by Julinda Mehilli at: TCT 2008 Plenary Session
5: Late Breaking Clinical Trials Ⅰ; October 14, 2008; Washington,
DC. |
| 2. |
FAME:
FFR Guided Stenting in Multivessel Disease
Source: Presented by Nico Pijls at: TCT 2008 Plenary Session
5: Late Breaking Clinical TrialsⅠ; October 14, 2008; Washington,
DC. |
| 3. |
ENDEAVOR
IV: 2-Year FU Comparing Zotarolimus- vs. Paclitaxel-Eluting
Stents
Source: Presented by Martin Leon at: TCT 2008 Plenary Session
6: “First Report” Randomized Trials & RegistriesⅠ; October
14, 2008; Washington, DC. |
| 4. |
ODESSA:
Using OCT to Evaluate Strut Coverage of Sirolimus-, Paclitaxel-
& Zotarolimus- Eluting Stents
Source: Presented by Giulio Guagliumi at: TCT 2008 Plenary Session
6: “First Report” Randomized Trials & RegistriesⅠ; October
14, 2008; Washington, DC. |
| 5. |
SOS:
Randomized Trials of Paclitaxel-Eluting vs. BMS in SVG Lesions
Source: Presented by Emmanouil Brilaki at: TCT 2008 Plenary
Session 6: “First Report” Randomized Trials & RegistriesⅠ;
October 14, 2008; Washington, DC. |
| 6. |
COOL
RCN : Randomized Trail of Systemic Hypothermia for Prevention
of Radiocontrast Nephropathy
Source: Presented by Gregg Stone at: TCT 2008 Plenary Session
6: “First Report” Randomized Trials & RegistriesⅠ; October
14, 2008; Washington, DC. |
| 7. |
HORIZONS
AMI AMI: Prospective Randomized Trials of Paclitaxel-Eluting
Stents vs. BMS in Patients with STEMI
Source: Presented by Gregg Stone at: TCT 2008 Plenary Session
13: Late Breaking Clinical Trials Ⅱ; October 15, 2008; Washington,
DC. |
| 8. |
HORIZONS
AMI: Bivalirudin vs. Unfractionated Heparin plus GPIIb/IIIa
Inhibitors in STEMI
Source: Presented by Roxana Mehran at: TCT 2008 Plenary Session
13: Late Breaking Clinical Trials Ⅱ; October 15, 2008; Washington,
DC. |
| 9. |
PREPARE:
Proximal Microcirculatory Protection in Patients with AMI Undergoing
Primary PCI
Source: Presented by Karel Koch at: TCT 2008 Plenary Session
13: Late Breaking Clinical Trials Ⅱ; October 15, 2008; Washington,
DC. |
| 10. |
ARNO:
Bivalirudin vs. Unfractionated Heparin plus Protamine in Patients
Undergoing Elective PCI
Source: Presented by David Antoniucci at: TCT 2008 Plenary Session
14: “First Report” Randomized Trials & Registries Ⅱ; October
15, 2008; Washington, DC. |
| 11. |
NAPLES:
Bivalirudin vs. Unfractionated Heparin plus Tirofiban in Patients
with Diabetes Undergoing Elective PCI
Source: Presented by Carlo Briguori at: TCT 2008 Plenary Session
14: “First Report” Randomized Trials & Registries Ⅱ; October
15, 2008; Washington, DC. |
| 12. |
ASSIST:
Early Eptifibatide Administration in Patients with AMI Undergoing
Primary PCI After Thienopyridine Loading
Source: Presented by Michel Le May at: TCT 2008 Plenary Session
14: “First Report” Randomized Trials & Registries Ⅱ; October
15, 2008; Washington, DC. |
| 13. |
FATA:
Tirofiban vs. Abciximab in Patients with AMI Undergoing Primary
PCI
Source: Presented by Francesco Saia at: TCT 2008 Plenary Session
14: “First Report” Randomized Trials & Registries Ⅱ; October
15, 2008; Washington, DC. |
| 14. |
SORT-OUT
III: Zotarolimus-Eluting Stents vs. Sirolimus-Eluting Stents
in CAD
Source: Presented by Jens Flensted Lassen at: TCT 2008 Plenary
Session 21: Late Breaking Clinical Trials Ⅲ; October 16, 2008;
Washington, DC. |
| 15. |
BBC
ONE: Single DES Provisional Strategy vs. Routine Dual DES for
Bifurcation Lesions
Source: Presented by David Hildick-Smith at: TCT 2008 Plenary
Session 21: Late Breaking Clinical Trials Ⅲ; October 16, 2008;
Washington, DC. |
| 16. |
ISAR-TEST
2: Polymer-Free DES, Polymer-Based DES & Zotarolimus-Eluting
Stents in CAD
Source: Presented by Robert Byrne at: TCT 2008 Plenary Session
21: Late Breaking Clinical Trials Ⅲ; October 16, 2008; Washington,
DC. |
| 17. |
DIVERGE:
Self-Expanding Drug-Eluting Bifurcation Stent Registry
Source: Presented by Stefan Verheye at: TCT 2008 Plenary Session
22: “First Report” Randomized Trials & Registries Ⅲ; October
16, 2008; Washington, DC. |
| 18. |
Western
Denmark Heart Registry: Zotarolimus-Eluting vs. Sirolimus-Eluting
Stents in CAD
Source: Presented by Leif Thuesen at: TCT 2008 Plenary Session
22: “First Report” Randomized Trials & Registries Ⅲ; October
16, 2008; Washington, DC. |
| 19. |
Western
Denmark Heart Registry: Zotarolimus-Eluting vs. Sirolimus-Eluting
Stents in CAD
Source: Presented by Leif Thuesen at: TCT 2008 Plenary Session
22: “First Report” Randomized Trials & Registries Ⅲ; October
16, 2008; Washington, DC. |
| 20. |
EMPIRE:
Neuroprotection in Carotid Stenting with a Flow Reversal System
Source: Presented by L. Nelson Hopkins at: TCT 2008 Plenary
Session 22: “First Report” Randomized Trials & Registries
Ⅲ; October 16, 2008; Washington, DC. |
| 21. |
EPIC:
Neuroprotection in Carotid Stenting with Distal Protection
Source: Presented by Subbatao Myla at: TCT 2008 Plenary Session
22: “First Report” Randomized Trials & Registries Ⅲ; October
16, 2008; Washington, DC. |
| 22. |
First-in-Human
Experience with a Stentless & Retrievable Percutaneous Aortic
Valve Prosthesis
Source: Presented by Joachim Schofer at: TCT 2008 Plenary Session
22: “First Report” Randomized Trials & Registries Ⅲ; October
16, 2008; Washington, DC. |
| |
|
